The second edition of NeuroconexiON recently brought together young neurologists to discuss the potential of artificial intelligence (AI) and new technologies in advancing Parkinson’s disease care.

During the event, Dr. Monica Kurtis presented the AI-PROGNOSIS project, showcasing its innovative approach to early detection, progression monitoring, and treatment support for Parkinson’s disease.

AI-PROGNOSIS is developing three digital tools to support Parkinson’s disease care:

• Risk Detection App: Identifies individuals at risk of developing Parkinson’s for earlier intervention.

• Progression Monitoring App: Tracks disease progression and responses to treatments.

• Clinical Decision Support App: Assists healthcare providers with critical information to guide treatment.

With AI and digital tools, AI-PROGNOSIS is making strides in understanding and addressing Parkinson’s disease, offering new hope for the Parkinson’s community.

The event was hosted by STADA Group.